102 related articles for article (PubMed ID: 7319754)
1. CT contrast enhancement of kidney V2 carcinoma after norepinephrine and acetylcholine injection.
Marincek B; Muller HH; Young SW
Invest Radiol; 1981; 16(6):487-90. PubMed ID: 7319754
[TBL] [Abstract][Full Text] [Related]
2. Computed tomography of rabbit V2 carcinoma after intraarterial contrast enhancement.
Young SW; Enzmann D; Marglin SI
J Comput Assist Tomogr; 1979 Apr; 3(2):185-8. PubMed ID: 429626
[TBL] [Abstract][Full Text] [Related]
3. A strategy for the contrast enhancement of malignant tumors using dynamic computed tomography and intravascular pharmacokinetics.
Young SW; Turner RJ; Castellino RA
Radiology; 1980 Oct; 137(1 Pt 1):137-47. PubMed ID: 7422835
[TBL] [Abstract][Full Text] [Related]
4. Contrast enhancement dynamic CT measurements and a mathematical model.
Cassel DM; Young SW; Turner R
Invest Radiol; 1982; 17(1):82-9. PubMed ID: 7076440
[No Abstract] [Full Text] [Related]
5. Time-related contrast enhancement of blood, normal muscle, and V2 carcinoma in the rabbit as determined by CT scanning.
Young SW; Rumbaugh CL
Invest Radiol; 1978; 13(4):334-6. PubMed ID: 689827
[TBL] [Abstract][Full Text] [Related]
6. Double-phase helical CT of small renal parenchymal neoplasms: correlation with pathologic findings and tumor angiogenesis.
Jinzaki M; Tanimoto A; Mukai M; Ikeda E; Kobayashi S; Yuasa Y; Narimatsu Y; Murai M
J Comput Assist Tomogr; 2000; 24(6):835-42. PubMed ID: 11105696
[TBL] [Abstract][Full Text] [Related]
7. Sequential changes in the CT numbers of the normal canine kidney following intravenous contrast administration. II: The renal medulla.
Brennan RE; Curtis JA; Pollack HM; Weinberg I
Invest Radiol; 1979; 14(3):239-45. PubMed ID: 468497
[TBL] [Abstract][Full Text] [Related]
8. Can high-attenuation renal cysts be differentiated from renal cell carcinoma at unenhanced CT?
Jonisch AI; Rubinowitz AN; Mutalik PG; Israel GM
Radiology; 2007 May; 243(2):445-50. PubMed ID: 17456870
[TBL] [Abstract][Full Text] [Related]
9. Optimal arterial phase imaging for detection of hypervascular hepatocellular carcinoma determined by continuous image capture on 16-MDCT.
Ma X; Samir AE; Holalkere NS; Sahani DV
AJR Am J Roentgenol; 2008 Sep; 191(3):772-7. PubMed ID: 18716108
[TBL] [Abstract][Full Text] [Related]
10. Optimal scan delays for multiphasic renal multidetector row computed tomography performed with fixed injection duration of contrast medium.
Tsuge Y; Kanematsu M; Goshima S; Kondo H; Hoshi H; Yokoyama R; Miyoshi T; Onozuka M; Moriyama N; Bae KT
J Comput Assist Tomogr; 2009; 33(1):101-5. PubMed ID: 19188795
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of renal neoplasms from high-density cysts: use of attenuation changes between the corticomedullary and nephrographic phases of computed tomography.
Zagoria RJ; Gasser T; Leyendecker JR; Bechtold RE; Dyer RB
J Comput Assist Tomogr; 2007; 31(1):37-41. PubMed ID: 17259831
[TBL] [Abstract][Full Text] [Related]
12. Contrast enhancement of malignant tumors after intravenous polyvinylpyrrolidone with metallic salts as determined by computed tomography.
Young SW; Muller HH; Marincek B
Radiology; 1981 Jan; 138(1):97-105. PubMed ID: 7455104
[TBL] [Abstract][Full Text] [Related]
13. Contrast enhancement by bolus technique in the CT examination of the kidney.
Baert AL; Wilms G; Marchal G; De Mayer P; De Somer F
Radiologe; 1980 Jun; 20(6):279-87. PubMed ID: 7403494
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a single-pass with biphasic intravenous contrast medium injection CT protocol for the assessment of complications post-simultaneous pancreas-kidney transplant.
Chung DY; Anderson EM
Clin Radiol; 2018 Jul; 73(7):677.e7-677.e11. PubMed ID: 29625745
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of gadobutrol in a rabbit model as a new lanthanide contrast agent for computed tomography.
Schmitz SA; Wagner S; Schuhmann-Giampieri G; Wolf KJ
Invest Radiol; 1995 Nov; 30(11):644-9. PubMed ID: 8557505
[TBL] [Abstract][Full Text] [Related]
16. The value of "liver windows" settings in the detection of small renal cell carcinomas on unenhanced computed tomography.
Sahi K; Jackson S; Wiebe E; Armstrong G; Winters S; Moore R; Low G
Can Assoc Radiol J; 2014 Feb; 65(1):71-6. PubMed ID: 23706868
[TBL] [Abstract][Full Text] [Related]
17. Uniform vascular enhancement of lower-extremity artery on CT angiography using test-injection monitoring at the central level of the scan range: a simulation flow phantom study with clinical correlation.
Shimizu K; Utsunomiya D; Nakaura T; Awai K; Oda S; Yanaga Y; Funama Y; Hirai T; Hashida M; Yamashita Y
Acad Radiol; 2010 Sep; 17(9):1153-7. PubMed ID: 20605732
[TBL] [Abstract][Full Text] [Related]
18. Computed tomographic enhancement of the liver, liver abscesses, spleen, and major vessels with perfluorooctylbromide emulsion. Influence of dosage and injection velocity in an animal model.
Adam G; Günther RW; Schiffer C; Görtz H; Prescher A; Scherer K
Invest Radiol; 1992 Sep; 27(9):698-705. PubMed ID: 1399453
[TBL] [Abstract][Full Text] [Related]
19. Multiphasic renal CT: comparison of renal mass enhancement during the corticomedullary and nephrographic phases.
Birnbaum BA; Jacobs JE; Ramchandani P
Radiology; 1996 Sep; 200(3):753-8. PubMed ID: 8756927
[TBL] [Abstract][Full Text] [Related]
20. INTRAARTERIAL INJECTION OF IODINATED CONTRAST MEDIUM FOR CONTRAST ENHANCED COMPUTED TOMOGRAPHY OF THE EQUINE HEAD.
Carmalt JL; Montgomery J
Vet Radiol Ultrasound; 2015; 56(4):384-90. PubMed ID: 25782997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
